SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
GENITOPE CORP
(NQPK:GTOP Last Sale: .0023 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQPK: (GTOP : $.0023)
$0 million Market Cap at September 12, 2013
Employs 20.
Biomedics SubIndustry up .00% / Health Industry up .00% Today

6900 Dumbarton Circle Research Report Earnings Snapshot - Last
Fremont, CA 94555 Annual Reports
Phone: 510-284-3000

Dan W. Denney, Jr., Chmn./CEO/Interim CFO
December 20, 2007 indicated therapy MyVax failed to slow the spread of non-Hodgkin's lymphoma. Stock fell July 26, 2006 on news trial of experimental cancer vaccine to continue for another year. Genitope had hoped that the early analysis would show that the vaccine, MyVax, improved disease-free survival in patients with follicular non-Hodgkin's lymphoma, a cancer of the lymphatic system, but it was not conclusive. IPO at $9 October 29, 2003. Raised $33.3 million, selling 3.7 million shares, 22% of the outstanding. Lead Manager: W.R. Hambrecht and Co. February 2008, FDA rejected an appeal from the company to accept a subset of trial data. May 2008, laid off 200 people and indicated is in default on $3.8 million in loans to GE, in negotiations with its landlord on 220,000 square feet, and could file bankruptcy.
Historical Charts    Technical Analysis
No Historical Data available for GTOP

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common GTOP $.0023 $ 0 $.0023 $.0028 320 $.0005 $.0176 42,984
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $99

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex